bpc-157 best time to take morning or evening Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved East Texas expert warns of
Description
The result could be more robust blood vessel networks delivering better nutrient supply to healing tissue
Also the rate-limiting steps for one substance may be in common with other substances

The Research Goal: Is the study looking for a minimal effective dose or a maximum tolerated dose

A., Zenkova, M
